Vertex Pharmaceuticals Inc (VRTX) Insider Trading
- $12,939,410.00
- $1,027,201,493.43
- March 10, 2025
- Joshua S Boger
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Oct. 5, 2016 | Director | 6,500 | $87.44 | Sell | $568,360.00 | |
Oct. 3, 2016 | EVP | 1,208 | $86.46 | Sell | $104,443.68 | |
Sept. 28, 2016 | Director | 6,500 | $88.15 | Sell | $572,975.00 | |
Sept. 21, 2016 | Director | 6,500 | $90.82 | Sell | $590,330.00 | |
Sept. 14, 2016 | Director | 6,500 | $92.37 | Sell | $600,405.00 | |
Sept. 7, 2016 | Director | 6,500 | $95.66 | Sell | $621,790.00 | |
Aug. 31, 2016 | Director | 6,500 | $94.62 | Sell | $615,030.00 | |
Aug. 24, 2016 | Director | 7,500 | $100.46 | Sell | $753,450.00 | |
Aug. 22, 2016 | Director | 1,100 | $100.79 | Sell | $110,869.00 | |
Aug. 17, 2016 | Director | 6,900 | $99.63 | Sell | $687,447.00 | |
Aug. 11, 2016 | Director | 900 | $100.19 | Sell | $90,171.00 | |
Aug. 10, 2016 | Director | 7,100 | $100.24 | Sell | $711,704.00 | |
Aug. 3, 2016 | Director | 47,000 | $100.66 | Sell | $4,731,020.00 | |
July 27, 2016 | Director | 6,500 | $95.93 | Sell | $623,545.00 | |
July 20, 2016 | Director | 6,500 | $90.33 | Sell | $587,145.00 | |
July 13, 2016 | Director | 6,500 | $88.81 | Sell | $577,265.00 | |
July 6, 2016 | Director | 5,140 | $88.99 | Sell | $457,408.60 | |
June 29, 2016 | Director | 5,130 | $84.82 | Sell | $435,126.60 | |
June 22, 2016 | Director | 5,130 | $86.61 | Sell | $444,309.30 | |
June 15, 2016 | Director | 5,130 | $91.18 | Sell | $467,753.40 | |
June 8, 2016 | Director | 5,130 | $94.95 | Sell | $487,093.50 | |
June 1, 2016 | Director | 5,130 | $93.65 | Sell | $480,424.50 | |
May 25, 2016 | Director | 5,130 | $89.09 | Sell | $457,031.70 | |
May 18, 2016 | Director | 5,130 | $81.18 | Sell | $416,453.40 | |
May 16, 2016 | EVP | 117 | $81.67 | Sell | $9,555.39 | |
May 16, 2016 | CFO | 202 | $82.06 | Sell | $16,576.12 | |
May 11, 2016 | Director | 5,130 | $86.50 | Sell | $443,745.00 | |
May 9, 2016 | SVP | 3,000 | $87.63 | Sell | $262,890.00 | |
May 4, 2016 | Director | 5,130 | $81.02 | Sell | $415,632.60 | |
April 27, 2016 | Director | 5,130 | $83.67 | Sell | $429,227.10 | |
April 20, 2016 | Director | 5,130 | $84.10 | Sell | $431,433.00 | |
April 13, 2016 | Director | 5,130 | $84.27 | Sell | $432,305.10 | |
April 6, 2016 | Director | 5,130 | $89.56 | Sell | $459,442.80 | |
March 30, 2016 | Director | 5,130 | $78.83 | Sell | $404,397.90 | |
March 23, 2016 | Director | 5,130 | $81.38 | Sell | $417,479.40 | |
March 16, 2016 | Director | 5,130 | $79.65 | Sell | $408,604.50 | |
March 2, 2016 | Director | 5,130 | $91.80 | Sell | $470,934.00 | |
Feb. 24, 2016 | Director | 5,130 | $85.25 | Sell | $437,332.50 | |
Feb. 17, 2016 | Director | 5,130 | $86.93 | Sell | $445,950.90 | |
Feb. 10, 2016 | Director | 5,130 | $82.57 | Sell | $423,584.10 | |
Feb. 3, 2016 | CFO | 12,084 | $90.84 | Sell | $1,097,710.56 | |
Feb. 3, 2016 | Director | 5,130 | $90.81 | Sell | $465,855.30 | |
Feb. 3, 2016 | EVP | 6,042 | $90.82 | Sell | $548,734.44 | |
Feb. 3, 2016 | SVP | 5,062 | $90.82 | Sell | $459,730.84 | |
Feb. 3, 2016 | CEO | 9,834 | $90.82 | Sell | $893,123.88 | |
Feb. 2, 2016 | CMO | 2,375 | $91.38 | Sell | $217,027.50 | |
Jan. 27, 2016 | Director | 11,200 | $93.22 | Sell | $1,044,064.00 | |
Jan. 20, 2016 | Director | 10,400 | $93.69 | Sell | $974,376.00 | |
Jan. 13, 2016 | Director | 10,400 | $98.41 | Sell | $1,023,464.00 | |
Jan. 6, 2016 | Director | 10,400 | $121.96 | Sell | $1,268,384.00 |
Insiders are both buying and selling Vertex Pharmaceuticals Inc stock.
The insider traders at Vertex Pharmaceuticals Inc are: Joshua S Boger, Paul M Silva, Stuart A Arbuckle, Jeffrey M Leiden, Amit Sachdev, Michael Parini, Jeffrey Chodakewitz, David Altshuler, Joshua S. Boger, Yuchun Lee, Reshma Kewalramani, Sangeeta N Bhatia, Ourania Tatsis, Ian F Smith, Bastiano Sanna, Bruce I Sachs, Joshua Boger, Peter Mueller, Charles F Wagner Jr, Carmen Bozic, Margaret G Mcglynn, Bruce Sachs, Elaine Ullian, Stuart A. Arbuckle, Kristen Ambrose, Jeffrey Leiden, Joy Liu, Kenneth L Horton, Megan E Pace, Megan Pace, Wayne Joseph Riley, Paul Silva, Thomas Graney, Christiana Stamoulis, Kenneth Horton, Sangeeta N. Bhatia, Ian F. Smith, Paul M. Silva, Terrence C Kearney, Thomas Connolly, Jeffrey M. Leiden, William D Young, Jonathan Biller, Edward Morrow Atkinson III, and Lloyd Carney
The most active insider trader at Vertex Pharmaceuticals Inc is Joshua S Boger with 99 trades.
Jeffrey M Leiden has sold the most Vertex Pharmaceuticals Inc stock with a total value of $395,375,749.22.
Reshma Kewalramani has bought the most Vertex Pharmaceuticals Inc stock with a total value of $17,310,520.00.
The most recent insider trade for Vertex Pharmaceuticals Inc was on March 10, 2025.
The single biggest insider buy for Vertex Pharmaceuticals Inc was from Reshma Kewalramani with a total value of $7,677,010.00 on July 30, 2024.
The single biggest insider sell for Vertex Pharmaceuticals Inc was from Jeffrey M Leiden with a total value of $37,164,389.02 on July 25, 2022.